High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report. RSD [Internet]. 2021 Oct. 5 [cited 2025 Dec. 5];10(13):e93101321104. Available from: https://rsdjournal.org/rsd/article/view/21104